Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Spyre Therapeutics Inc., 3 years.
Spyre Therapeutics Inc.
Director
TCGX Acquisition Corp. II
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Spyre Therapeutics Inc. | Open-market sale | −20,000 | $100.00 | $2,000,000 |
| May 8, 2026 | Spyre Therapeutics Inc. | Open-market sale | −2,404 | $72.57 | $174,458 |
| May 8, 2026 | Spyre Therapeutics Inc. | Open-market sale | −33,513 | $73.72 | $2,470,578 |
| May 8, 2026 | Spyre Therapeutics Inc. | Open-market sale | −24,814 | $74.76 | $1,855,095 |
| May 8, 2026 | Spyre Therapeutics Inc. | Open-market sale | −19,269 | $75.35 | $1,451,919 |
| Jan 21, 2026 | Spyre Therapeutics Inc. | Other | +63,227 | — | — |
| Jan 10, 2025 | Spyre Therapeutics Inc. | Other | +105,379 | — | — |
Questions about Michael Thomas Henderson
What boards is Michael Thomas Henderson on?
Michael Thomas Henderson sits on the boards of Spyre Therapeutics Inc. and TCGX Acquisition Corp. II.
How long has Michael Thomas Henderson served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.